SRI and cancer: The same study reports a correlation of sorcin expression with patient survival, clinical features, cancer stem cell properties, tumor mutation burden, microsatellite instability, and immune cell infiltration; aberrant sorcin expression and/or gene amplification was also found related to epithelial-mesenchymal-transition (EMT), tumor immune microenvironment, and drug resistance (see below) [91].